BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27218789)

  • 1. Sebaceous Carcinoma of the Eyelid.
    Prieto-Granada C; Rodriguez-Waitkus P
    Cancer Control; 2016 Apr; 23(2):126-32. PubMed ID: 27218789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
    Mulay K; White VA; Shah SJ; Honavar SG
    Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
    Jakobiec FA; Mendoza PR
    Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management.
    Dini F; Susini P; Nisi G; Cuomo R; Grimaldi L; Massi D; Innocenti A; Doni L; Mazzini C; Santoro N; De Giorgi V
    Int J Dermatol; 2024 Jun; 63(6):726-736. PubMed ID: 38351466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
    Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
    Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kissing tumors of sebaceous carcinoma on the eyelids in collision with melanocytic nevus: A case report.
    Lin YC; Chen WC; Wu CS; Liao JB; Wei KC
    J Dermatol; 2016 Apr; 43(4):447-9. PubMed ID: 26661447
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular sebaceous gland carcinoma: an update of the literature.
    Cicinelli MV; Kaliki S
    Int Ophthalmol; 2019 May; 39(5):1187-1197. PubMed ID: 29696467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA; Werdich X
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceous carcinoma with apocrine differentiation: a rare entity with aggressive behavior.
    Afroz N; Zaidi N; Rizvi SA
    Indian J Pathol Microbiol; 2013; 56(4):408-10. PubMed ID: 24441233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological review of sebaceous carcinoma of the eyelid.
    Pereira PR; Odashiro AN; Rodrigues-Reyes AA; Correa ZM; de Souza Filho JP; Burnier MN
    J Cutan Pathol; 2005 Aug; 32(7):496-501. PubMed ID: 16008694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
    Milman T; Schear MJ; Eagle RC
    Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma.
    Lai TF; Huilgol SC; Selva D; James CL
    Dermatol Surg; 2004 Feb; 30(2 Pt 1):222-5. PubMed ID: 14756656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.